An older smoker with wheezing, hyperinflation, and hypoxemia can look like “just another COPD exacerbation.” That shortcut is dangerous when orthopnea, elevated jugular venous pressure, edema, bibasilar crackles, and upper-lobe vascular redistribution point to pulmonary venous congestion. The high-stakes question is not whether the patient has heart failure or COPD as mutually exclusive diagnoses; it is which physiology is driving the immediate respiratory failure and what must be treated first.
A mixed case is possible—and clinically important
Consider a 71-year-old woman with COPD, obesity, long-standing hypertension, and a 40-pack-year smoking history. Over three days, she becomes breathless while walking across the room, sleeps upright in a recliner, and notices new ankle swelling. Her cough produces scant clear sputum. She is tachypneic and hypoxemic, with diffuse expiratory wheezing, bibasilar fine crackles, and a clearly elevated JVP. Chest imaging shows hyperinflation alongside interstitial edema.
This is not a contest between two neat labels. Pulmonary edema can produce wheeze through airway narrowing, sometimes called cardiac asthma. Conversely, an acute COPD exacerbation can increase intrathoracic pressure, sympathetic tone, and cardiac workload, precipitating or worsening heart failure.
Before calling the chronic syndrome HFpEF, establish the missing baseline. In an acute presentation, it is safer to call this suspected acute heart failure until the EF and objective evidence of elevated filling pressures or cardiogenic congestion are documented. Ask about usual walking distance, home oxygen, prior PaCO₂ or bicarbonate values, baseline pillow use, previous edema, recent weight change, inhaler adherence, diuretic interruption, sleep-disordered breathing, fever, viral symptoms, sputum volume and purulence, pleuritic pain, and thromboembolic risk.
Let the pattern, not one finding, drive the differential
| Finding | More supportive of acute heart failure | More supportive of COPD exacerbation |
|---|---|---|
| Orthopnea, paroxysmal nocturnal dyspnea, rapid weight gain | Strong clue to congestion | Less typical, though upright posture may ease breathing |
| Wheeze, prolonged expiration, increased cough | May occur with pulmonary edema | Supports airflow obstruction |
| JVP elevation, S4, bilateral edema | Supports congestion or reduced ventricular compliance | Consider cor pulmonale, but not typical of an isolated flare |
| Purulent sputum, fever, infectious prodrome | May indicate a trigger rather than the primary syndrome | Supports an infectious trigger, but is not required for an exacerbation |
| B-lines, Kerley lines, cephalization, pleural effusions | Supports pulmonary congestion | Not explained by uncomplicated COPD |
Clear or white sputum lowers suspicion for bacterial infection but does not exclude COPD exacerbation. Similarly, wheezing does not prove that airflow obstruction is the dominant problem. The combination of positional dyspnea, venous congestion, and interstitial edema deserves more weight than the presence of wheeze alone.
Use tests as probability shifters
A chest radiograph showing both hyperinflation and interstitial edema is not contradictory. It may be the most useful clue that two processes are active. Point-of-care ultrasound can add information: diffuse bilateral B-lines, pleural effusions, and venous congestion can support volume or pressure overload, while focused cardiac views may identify reduced LV systolic function or right-heart strain. B-lines are not specific, however; pneumonia and interstitial lung disease can produce them as well. Diastolic dysfunction and filling-pressure assessment generally require a formal echocardiographic examination, and no isolated parameter establishes HFpEF.
The ECG may reveal LVH, ischemia, or arrhythmia, but a nondiagnostic tracing does not exclude acute heart failure. Check troponin, CBC, electrolytes, renal function, glucose, and viral testing when appropriate. Reassess for pulmonary embolism, pneumonia, pneumothorax, acute coronary syndrome, and tachyarrhythmia when the clinical pattern is not fully explained.
A natriuretic peptide is useful, but it is not a verdict. Obesity lowers BNP and NT-proBNP concentrations and can mask HFpEF, so a low or modest result is less reassuring in severe obesity than it would be otherwise. At the same time, age, renal dysfunction, atrial fibrillation, pulmonary hypertension, and critical illness can elevate natriuretic peptides without proving left-sided HF.
To diagnose HFpEF rather than simply “acute heart failure with EF not yet known,” the patient needs a compatible heart-failure syndrome, an LVEF of at least 50%, and objective evidence of increased filling pressures or cardiogenic congestion, documented at rest or, when necessary, with provocation. Echocardiography should assess EF, LVH, left atrial size, diastolic indices, right-sided pressure estimates, and valvular disease. No single Doppler measurement establishes HFpEF in isolation.
Read the ABG without overcalling chronicity
Suppose the ABG is pH 7.29, PaCO₂ 65 mmHg, HCO₃⁻ 30 mmol/L, and PaO₂ 54 mmHg. This is acute hypercapnic respiratory failure with acidemia. The elevated bicarbonate suggests some chronic renal compensation, but it does not prove a stable baseline of chronic CO₂ retention. Prior blood gases or chemistry panels are more reliable.
The bicarbonate lies between the expected values for a purely acute and a purely chronic respiratory acidosis. If the bicarbonate is lower than expected for the presumed chronic compensation, check for a concurrent metabolic acidosis rather than forcing the result into a simple acute-on-chronic label.
Treat the physiology while clarifying the cause
The first hour should address oxygenation, ventilatory failure, bronchospasm, congestion, and reversible triggers in parallel.
| Immediate move | Why it matters | Safety check |
|---|---|---|
| Controlled oxygen, initially targeting 88–92% in a patient at risk for hypercapnia | Corrects hypoxemia while reducing the risk of worsening CO₂ retention | Repeat gas measurement; temporarily use higher oxygen if immediately life-threatening hypoxemia requires it |
| Bilevel NIV for hypercapnic acidemia and marked work of breathing | Improves alveolar ventilation and unloads respiratory muscles; positive pressure can also help cardiogenic pulmonary edema | Continuous monitoring, mask tolerance, mental status, secretions, and readiness for intubation |
| IV loop diuretic when clinical congestion is convincing | Relieves volume overload and pulmonary venous pressure | Track urine output, renal function, blood pressure, sodium, and potassium |
| Short-acting bronchodilator, often combined with ipratropium | Treats reversible bronchospasm | Beta-agonists may worsen tachycardia and lower potassium, especially with diuresis |
| Short systemic corticosteroid course if a significant COPD exacerbation remains likely | Reduces airway inflammation and shortens recovery in appropriate exacerbations | Monitor glucose, delirium, infection, and fluid status; avoid unnecessarily prolonged therapy |
| Antibiotics when increased sputum purulence plus another compatible symptom, a prior positive sputum culture during a previous exacerbation, or mechanical ventilation supports use | Treats patients more likely to benefit while limiting unnecessary exposure | Clear sputum alone is not an indication; evaluate pneumonia separately and follow local resistance patterns |
In a patient with pH below 7.35, elevated PaCO₂, respiratory distress, and no immediate contraindication, NIV is usually the preferred initial ventilatory strategy. If pulmonary edema dominates without hypercapnic acidemia, CPAP may be sufficient; when both ventilatory failure and congestion are present, bilevel support is often more appropriate. Failure to improve gas exchange, work of breathing, or mental status should prompt early escalation rather than prolonged NIV trials.
Current GOLD criteria support antibiotics when a COPD exacerbation has at least two of increased dyspnea, fever, sputum volume, and sputum purulence, provided purulence is one of them; when a prior positive sputum culture during a previous exacerbation is relevant; or when invasive or noninvasive mechanical ventilation is required. Pneumonia should be treated according to its own clinical and radiographic diagnosis.
Do not reflexively give large fluid volumes for “thick secretions” when JVP, edema, and radiographic congestion are present. Likewise, do not withhold bronchodilators solely because the patient has heart failure; administer them judiciously and monitor the cardiac response.
Common traps on rounds and exams
- Wheeze equals COPD. Pulmonary edema can cause prominent wheezing.
- BNP 420 proves HFpEF. It supports heart failure in context, but EF and evidence of elevated filling pressures still matter.
- No purulent sputum means no COPD exacerbation. It argues against a bacterial trigger, not against an exacerbation itself.
- More oxygen is always better. In hypercapnia-prone patients, uncontrolled oxygen can worsen CO₂ retention and acidosis.
- An elevated bicarbonate proves chronic hypercapnia. It suggests compensation but must be compared with prior results.
- Preserved EF means no heart failure. HFpEF is a syndrome of congestion and abnormal filling, not simply a normal ejection fraction.
After stabilization, confirm the phenotype with echocardiography, reassess oxygen needs and inhaler technique, optimize blood pressure and volume management, and evaluate obesity-related hypoventilation or sleep apnea when clinically indicated. If HFpEF is confirmed or strongly supported, longer-term therapy should be individualized; diuretics control congestion, while contemporary guidance supports consideration of an SGLT2 inhibitor and careful management of cardiometabolic comorbidities.
Smoking cessation should be treated as part of the acute-care plan rather than a final sentence in the discharge summary. Varenicline is generally the most effective single pharmacotherapy, while combination nicotine replacement is another effective option. Both work best when paired with counseling and arranged follow-up.
Practical takeaways
- In older smokers, COPD and acute heart failure frequently coexist; avoid single-diagnosis anchoring.
- Orthopnea, JVP elevation, edema, S4, B-lines, and vascular redistribution are high-value clues to congestion.
- Obesity can make natriuretic peptide levels look deceptively modest, especially in HFpEF; a low result does not reliably exclude it.
- pH 7.29 with PaCO₂ 65 is an indication to think about acute hypercapnic respiratory failure, not simply “severe COPD.”
- Use controlled oxygen, early NIV when acidemic hypercapnia is present, bronchodilators, and decongestion according to the dominant physiology.
- Treat the trigger, document the true baseline, and do not label HFpEF from preserved EF alone.